Cefoxitin (CFX) versus Piperacillin-Tazobactam (PTZ) for the Treatment of Mild-to-Moderate Complicated Intra-Abdominal Infections (cIAI) in an Era of Increased Anaerobic Resistance | Zendy

AI Assistant Blog Pricing

Cefoxitin (CFX) versus Piperacillin-Tazobactam (PTZ) for the Treatment of Mild-to-Moderate Complicated Intra-Abdominal Infections (cIAI) in an Era of Increased Anaerobic Resistance

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.